Trifluoroacetic acid → HCID 59682929, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([O:14][C:15]2[CH:24]=[C:23]3[C:18]([C:19]([O:25][C:26]4[CH:34]=[C:33]5[C:29]([CH:30]=[C:31]([CH3:35])[NH:32]5)=[CH:28][CH:27]=4)=[N:20][CH:21]=[N:22]3)=[CH:17][C:16]=2[O:36][CH3:37])[CH2:10][CH2:9]1)=O)(C)(C)C.C(O)(C(F)(F)F)=O>ClCCl>[CH3:37][O:36][C:16]1[CH:17]=[C:18]2[C:23](=[CH:24][C:15]=1[O:14][CH:11]1[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]1)[N:22]=[CH:21][N:20]=[C:19]2[O:25][C:26]1[CH:34]=[C:33]2[C:29]([CH:30]=[C:31]([CH3:35])[NH:32]2)=[CH:28][CH:27]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
7-{[1-(tert-Butoxycarbonyl)-piperidin-4-yl]oxy}-6-methoxy-4-[(2-methyl-1H-indol-6-yl)oxy]quinazoline (1 g) was dissolved in dichloromethane (5 ml) and cooled in an ice bath. TFA (2.5 ml) was added and the reaction mixture stirred at this temperature for 35 minutes. The volatiles were removed by filtration and the residue taken up into ice cold water. The pH was adjusted to 12 with sodium hydroxide 2N and extracted twice with dichloromethane. The combined extracts were washed in turn with water and brine and dried over magnesium sulphate and the solvent evaporated under vacuum to give 6-methoxy-4-[(2-methyl-1H-indol-6-yl)oxy]-7-[(piperidin-4-yl)oxy]quinazoline (0.765 g) as a solid foam.
Workup
- temperaturecooled in an ice bath
- customThe volatiles were removed by filtration
- extractionextracted twice with dichloromethane
- washThe combined extracts were washed in turn with water and brine
- dry with materialdried over magnesium sulphate
- customthe solvent evaporated under vacuum
Sources & evidence
- ORD record
- ord-129d1c90312a4c44b2286e3d423e330c
- Source dataset
- uspto-grants-2011_08
- Patent number
- US07989460B2
Reaction notes
Loading…